Why the study?
Takotsubo cardiomyopathy can lead to serious LVOT obstruction with cardiogenic shock, where early identification and optimal acute therapeutic management are critical.
Does intravenous landiolol reduce LVOT gradient in patients with Takotsubo cardiomyopathy and haemodynamic instability?
Does intravenous landiolol reduce LVOT gradient in patients with Takotsubo cardiomyopathy and haemodynamic instability?
Intravenous landiolol may be an effective acute treatment for releasing dynamic LVOT obstruction in patients with Takotsubo cardiomyopathy and haemodynamic instability.
Answers are grounded in this paper and cite their sources.
LVOT obstruction may complicate TCM shock; hypothesis-generating and should not yet change practice.
Takotsubo cardiomyopathy (TCM) leads to serious left ventricular outflow tract (LVOT) obstruction with cardiogenic shock in 6%-20% of cases. The onset of LVOT obstruction, coupled with mitral regurgitation resulting from systolic anterior motion of mitral valve leaflets, can lead to haemodynamic instability in addition to severely impaired systolic function. We describe three patients who experienced chest discomfort following emotional stress. These patients displayed pronounced abnormalities on ECGs, insignificant obstructive coronary disease and haemodynamic instability due to LVOT obstruction. The infusion of landiolol, a short-acting beta blocker, was effective in releasing the gradient. Dynamic outflow obstruction is the major predictor of haemodynamic collapse. We suggested that an early identification of this complication in hypotensive patients with suspected TCM could be of utmost importance to optimise the therapeutic approach in the acute setting.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: